MARKET

ARTL

ARTL

Artelo Biosciences Inc
NASDAQ
1.470
+0.100
+7.30%
After Hours: 1.480 +0.01 +0.68% 19:13 02/06 EST
OPEN
1.400
PREV CLOSE
1.370
HIGH
1.510
LOW
1.355
VOLUME
23.42K
TURNOVER
--
52 WEEK HIGH
28.60
52 WEEK LOW
1.150
MARKET CAP
2.97M
P/E (TTM)
-0.0704
1D
5D
1M
3M
1Y
5Y
1D
Artelo Biosciences Secures Flexible Multiyear Equity Financing
TipRanks · 2d ago
Artelo Biosciences Announces $25 Million Private Placement Agreement
Reuters · 2d ago
Artelo Biosciences Granted Nasdaq Extension to Regain Compliance
TipRanks · 2d ago
Weekly Report: what happened at ARTL last week (0126-0130)?
Weekly Report · 5d ago
Artelo Biosciences Shareholders Back Board, Pay and Auditor
TipRanks · 01/30 21:32
Artelo Biosciences Inc. held annual shareholder meeting
Reuters · 01/30 21:11
Weekly Report: what happened at ARTL last week (0119-0123)?
Weekly Report · 01/26 09:44
Weekly Report: what happened at ARTL last week (0112-0116)?
Weekly Report · 01/19 09:47
More
About ARTL
Artelo Biosciences, Inc. is a clinical-stage pharmaceutical company dedicated to the development and commercialization of therapeutics that modulate lipid-signaling pathways. The Company is advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, anxiety, dermatologic conditions, pain, and inflammation. Its pipeline products include ART26.12, ART27.13 and ART12.11. ART26.12, its Fatty Acid Binding Protein 5 (FABP5) inhibitor, is being developed as a novel, peripherally acting, non-opioid, non-steroidal analgesic. The Cancer Appetite Recovery Study (CAReS) is a Phase 1/2 randomized, placebo-controlled trial of its clinical program, ART27.13, in patients with cancer anorexia and weight loss. ART12.11, the Company's novel solid-state cannabidiol composition co-formed with tetramethylpyrazine, is targeted for development in anxiety disorders and rare/orphan diseases.

Webull offers Artelo Biosciences Inc stock information, including NASDAQ: ARTL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARTL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARTL stock methods without spending real money on the virtual paper trading platform.